Is the Use of SGLT-2 Associated with an Increased Risk of Cancer?

Md Sadique Hussain; Gyas Khan; Gaurav Gupta

doi:10.2174/0115680096383119250307083130

Is the Use of SGLT-2 Associated with an Increased Risk of Cancer?

Md Sadique Hussain
, Gyas Khan
, Gaurav Gupta

Center of Medical and Bio-allied Health Sciences Research (CMBHSR)

Uttaranchal University
Jazan University
Chitkara University

Research output: Contribution to journal › Editorial

3 Scopus citations

Original language	English
Pages (from-to)	871-873
Number of pages	3
Journal	Current Cancer Drug Targets
Volume	25
Issue number	8
DOIs	https://doi.org/10.2174/0115680096383119250307083130
State	Published - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antidiabetic agents
canagliflozin
cancer risk
dapagliflozin
empagliflozin
randomized controlled trials

Access to Document

10.2174/0115680096383119250307083130

Cite this

@article{91585ce43dac46aab5647ebcb1e6a691,

title = "Is the Use of SGLT-2 Associated with an Increased Risk of Cancer?",

keywords = "Antidiabetic agents, canagliflozin, cancer risk, dapagliflozin, empagliflozin, randomized controlled trials",

author = "Hussain, \{Md Sadique\} and Gyas Khan and Gaurav Gupta",

year = "2025",

doi = "10.2174/0115680096383119250307083130",

language = "English",

volume = "25",

pages = "871--873",

journal = "Current Cancer Drug Targets",

issn = "1568-0096",